摘要
目的:探讨吡美莫司(ASM 981)联合电针治疗特异性皮炎(AD)的有效性和安全性。方法:32例AD患者随机分为联合组、ASM 981组和电针组。ASM 981组使用1%吡美莫司软膏外涂(2次/天);电针组使用电针针刺曲池、血海、足三里、三阴交;联合组联合ASM 981和电针治疗,治疗4周后观察各组临床疗效及并发症。结果:与ASM981组和电针组比较,联合组有效率显著增高(P<0.01),带状疱疹发病率显著降低(P<0.01)。结论:ASM981联合电针治疗特异性皮炎作用及安全性优于单独治疗组。
Objective：To investigate the effect of pimecrolimus （ ASM 981） combined with electroacupuncture （ EA） on atopic dermatitis（ AD） .Methods：32 patients were randomly divided into an EA group,an ASM 981 group and an EA＋ASM 981 group.Pimecrolimus ointment 1% was used in ASM 981 group twice daily;EA treatment was applied to“Quchi”,“Xuehai”,“Zusanli”and“Sanyinjiao”in the EA group;the EA＋ASM 981 group was combined EA with ASM 981, 4 weeks after treatment, the curative effect and complication were ob -served.Results：Compared with EA group and ASM 981 group, the clinically effective rate was significantly in -creased in the EA＋ASM 981 group （ P〈0 .01 ） , and the herpes zoster rate was decreased （ P〈0 .01 ） .Con-clusion：The combined treatment promotes the clinically effective rate and security significantly and is better than either of the single treatment for AD.
出处
《针灸临床杂志》
2015年第2期13-15,共3页
Journal of Clinical Acupuncture and Moxibustion
